Beyond Medical Technologies Inc. (DOCT.CN)
CAD 0.04
(0.0%)
CAD 0.04
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -527.04 Thousand | -894 Thousand | -1.39 Million | -1.83 Million | -2.39 Million | -1.85 Million |
| Net Income | -552 Thousand | -1.4 Million | -2.91 Million | -6.52 Million | -5.36 Million | -3.2 Million |
| Depreciation & Amortization | - | - | 173.08 Thousand | 142.36 Thousand | 120.26 Thousand | 25.27 Thousand |
| Deferred income taxes | - | - | 433.77 Thousand | 213.38 Thousand | - | - |
| Stock-based compensation | - | 122.55 Thousand | 200.34 Thousand | 7070.00 | 349.49 Thousand | 808.02 Thousand |
| Change in working capital | 51.37 Thousand | 92.87 Thousand | 291.79 Thousand | 84.02 Thousand | -86.38 Thousand | 165.81 Thousand |
| Other non-cash items | -29.6 Thousand | 291.4 Thousand | 414.71 Thousand | 4.24 Million | 2.58 Million | 350.57 Thousand |
| Investing Cash Flow | - | - | -467.98 Thousand | -260.27 Thousand | 1.82 Million | -4.61 Million |
| Investments in PPE | - | - | -67.98 Thousand | -234.11 Thousand | -33.38 Thousand | -201.24 Thousand |
| Acquisitions | - | - | - | -308.94 Thousand | 3000.00 | - |
| Investment purchases | - | - | -400 Thousand | 5103.00 | -3000.00 | -3 Million |
| Sales/Maturities of investments | - | - | - | 257.13 Thousand | 3 Million | - |
| Other Investing Activities | - | - | -67.98 Thousand | 20.55 Thousand | -1.14 Million | -1.41 Million |
| Financing Cash Flow | 30 Thousand | - | 2.67 Million | -65.95 Thousand | 281.03 Thousand | 4.95 Million |
| Debt repayment | -30 Thousand | - | -79.92 Thousand | -65.95 Thousand | -56.46 Thousand | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 2.7 Million | - | 337.5 Thousand | 2.3 Million |
| Other Financing Activities | 30 Thousand | - | 51.75 Thousand | -65.96 | 281.03 | 2.65 Million |
| Accounts receivables | 3192.00 | 12.56 Thousand | 28.23 Thousand | 43.99 Thousand | 50.44 Thousand | -103.75 Thousand |
| Accounts payables | 23.23 Thousand | 60.39 Thousand | -12.28 Thousand | 257.21 Thousand | - | 182.73 Thousand |
| Inventory | - | -12.56 Thousand | 46.59 Thousand | -188.42 Thousand | - | 136.82 Thousand |
| Other working capital | 48.18 Thousand | 32.47 Thousand | 229.24 Thousand | -28.75 Thousand | -136.82 Thousand | -50 Thousand |
| Cash at beginning of period | 536.75 Thousand | 1.43 Million | 624.2 Thousand | 2.78 Million | 3.08 Million | 4.57 Million |
| Cash at end of period | 64.14 Thousand | 536.75 Thousand | 1.43 Million | 624.2 Thousand | 2.78 Million | 3.08 Million |
| Capital Expenditure | - | - | -67.98 Thousand | -234.11 Thousand | -33.38 Thousand | -201.24 Thousand |
| Effect of forex changes on cash | - | - | - | -59.00 | -2783.00 | 19.47 Thousand |
| Net cash flow / Change in cash | -472.61 Thousand | -894 Thousand | 806.55 Thousand | -2.16 Million | -297.04 Thousand | -1.49 Million |
| Free Cash Flow | -527.04 Thousand | -894 Thousand | -1.46 Million | -2.06 Million | -2.43 Million | -2.05 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -58.2 Thousand | -64.64 Thousand | -552 Thousand | -150.89 Thousand | -100.3 Thousand | -105.24 Thousand |
| Depreciation & Amortization | - | - | - | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 80.31 Thousand | 33.73 Thousand | 51.37 Thousand | 106.57 Thousand | 4904.00 | 29.33 Thousand |
| Other non-cash items | -58.4 Thousand | -14.1 Thousand | -29.6 Thousand | -11.44 Thousand | -907.00 | -69.14 Thousand |
| Investing Cash Flow | - | - | - | - | - | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | - | 30 Thousand | 30 Thousand | 30 Thousand | - | - |
| Debt repayment | - | -30 Thousand | -30 Thousand | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | 30 Thousand | 30 Thousand | 30 Thousand | - | - |
| Accounts receivables | 124.00 | -891.00 | 3192.00 | 3971.00 | 2391.00 | -2468.00 |
| Accounts payables | -849.00 | -32.58 Thousand | 23.23 Thousand | 53.68 Thousand | 1463.00 | -27.4 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | 80.19 Thousand | 34.62 Thousand | 48.18 Thousand | 102.6 Thousand | 1050.00 | 59.21 Thousand |
| Cash at beginning of period | 48.22 Thousand | 64.14 Thousand | 536.75 Thousand | 61.49 Thousand | 157.8 Thousand | 302.84 Thousand |
| Cash at end of period | 12.06 Thousand | 48.22 Thousand | 64.14 Thousand | 64.14 Thousand | 61.49 Thousand | 157.8 Thousand |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -36.16 Thousand | -15.91 Thousand | -472.61 Thousand | 2646.00 | -96.3 Thousand | -145.04 Thousand |
| Free Cash Flow | -36.16 Thousand | -45.91 Thousand | -527.04 Thousand | -51.78 Thousand | -96.3 Thousand | -145.04 Thousand |
AJBU
SPFI
NBYCF
8444
LTHM
GES